Hypoxia-induced mitogenic factor enhances angiogenesis by promoting proliferation and migration of endothelial cells

Experimental Cell Research

Volumn 312, Issue 18, 2006, Pages 3559-3569

  Tong, Qiangsong ^a   Zheng, Liduan ^b   Li, Bo ^a   Wang, Danming ^a   Huang, Chuanshu ^c   Matuschak, George M ^a   Li, Dechun ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNION HOSPITAL   (China)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Endothelial cells; Hypoxia induced mitogenic factor; Signal transduction

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CD31 ANTIGEN; HYPOXIA INDUCED MITOGENIC FACTOR; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P85; PROTEIN TYROSINE KINASE INHIBITOR; RECOMBINANT PROTEIN; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL CELL; AORTA; ARTERY ENDOTHELIUM; ARTICLE; CELL CULTURE; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; CELL SPREADING; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; FUNCTIONAL PROTEOMICS; GENETIC TRANSFECTION; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 33749341504     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2006.07.024     Document Type: Article

References (41)

1. Folkman J., and Shing Y. Angiogenesis. J. Biol. Chem. 267 (1992) 10931-10934
2. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
3. Munoz-Chapuli R., Quesada A.R., and Medina Angel M. Angiogenesis and signal transduction in endothelial cells. Cell. Mol. Life Sci. 61 (2004) 2224-2243
4. Veikkola T., Karkkainen M., Claesson-Welsh L., and Alitalo K. Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res. 60 (2000) 203-212
5. Tomita N., Morishita R., Taniyama Y., Koike H., Aoki M., Shimizu H., Matsumoto K., Nakamura T., Kaneda Y., and Ogihara T. Angiogenic property of hepatocyte growth factor is dependent on upregulation of essential transcription factor for angiogenesis, ets-1. Circulation 107 (2003) 1411-1417
6. Friesel R.E., and Maciag T. Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J. 9 (1995) 919-925
7. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., Sato T.N., and Yancopoulos G.D. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87 (1996) 1171-1180
8. Grove A.D., Prabhu V.V., Young B.L., Lee F.C., Kulpa V., Munson P.J., and Kohn E.C. Both protein activation and gene expression are involved in early vascular tube formation in vitro. Clin. Cancer Res. 8 (2002) 3019-3026
9. Teng X., Li D., Champion H.C., and Johns R.A. FIZZ1/RELM{alpha}, a novel hypoxia-induced mitogenic factor in lung with vasoconstrictive and angiogenic properties. Circ. Res. 92 (2003) 1065-1067
10. Li D., Fernandez L.G., Dodd-o J., Langer J., Wang D., and Laubach V.E. Upregulation of hypoxia-induced mitogenic factor in compensatory lung growth after pneumonectomy. Am. J. Respir. Cell Mol. Biol. 32 (2005) 185-191
11. Wagner K.F., Hellberg A.K., Balenger S., Depping R., Dodd O., Johns R.A., and Li D. Hypoxia-induced mitogenic factor has antiapoptotic action and is upregulated in the developing lung: coexpression with hypoxia-inducible factor-2{alpha}. Am. J. Respir. Cell Mol. Biol. 31 (2004) 276-282
12. Tong Q., Zheng L., Dodd-o J., Langer J., Wang D., and Li D. Hypoxia-induced mitogenic factor modulates surfactant protein B and C expression in mouse lung. Am. J. Respir. Cell Mol. Biol. 34 (2006) 28-38
13. Tong Q., Zheng L., Lin L., Li B., Wang D., Huang C., and Li D. VEGF is upregulated by hypoxia-induced mitogenic factor via the PI-3K/Akt-NF-kB signaling pathway. Respir. Res. 7 (2006) 37
14. Nicosia R.F., and Ottinetti A. Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab. Invest. 63 (1990) 115-122
15. Voyta J.C., Via D.P., Butterfield C.E., and Zetter B.R. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J. Cell Biol. 99 (1984) 2034-2040
16. Huang C., Ma W.Y., and Dong Z. Requirement for phosphatidylinositol 3-kinase in epidermal growth factor-induced AP-1 transactivation and transformation in JB6 P+ cells. Mol. Cell. Biol. 16 (1996) 6427-6435
17. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
18. Lebrin F., Goumans M.J., Jonker L., Carvalho R.L., Valdimarsdottir G., Thorikay M., Mummery C., Arthur H.M., and ten Dijke P. Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction. EMBO J. 23 (2004) 4018-4028
19. Tarui T., Majumdar M., Miles L.A., Ruf W., and Takada Y. Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin. J. Biol. Chem. 277 (2002) 33564-33570
20. Deregibus M.C., Buttiglieri S., Russo S., Bussolati B., and Camussi G. CD40-dependent activation of phosphatidylinositol 3-kinase/Akt pathway mediates endothelial cell survival and in vitro angiogenesis. J. Biol. Chem. 278 (2003) 18008-18014
21. Zhu W.H., Iurlaro M., MacIntyre A., Fogel E., and Nicosia R. The mouse aorta model: influence of genetic background and aging on bFGF- and VEGF-induced angiogenic sprouting. Angiogenesis 6 (2003) 193-199
22. Strawn L.M., McMahon G., App H., Schreck R., Kuchler W.R., Longhi M.P., Hui T.H., Tang C., Levitzki A., Gazit A., Chen I., Keri G., Orfi L., Risau W., Flamme I., Ullrich A., Hirth K.P., and Shawver L.K. Flk-1 as a target for tumor growth inhibition. Cancer Res. 56 (1996) 3540-3545
23. Auerbach R., Lewis R., Shinners B., Kubai L., and Akhtar N. Angiogenesis assays: a critical overview. Clin. Chem. 49 (2003) 32-40
24. Malinda K.M., Nomizu M., Chung M., Delgado M., Kuratomi Y., Yamada Y., Kleinman H.K., and Ponce M.L. Identification of laminin {alpha}1 and beta1 chain peptides active for endothelial cell adhesion, tube formation, and aortic sprouting. FASEB J. 13 (1999) 53-62
25. Blacher S., Devy L., Burbridge M.F., Roland G., Tucker G., Noel A., and Foidart J.M. Improved quantification of angiogenesis in the rat aortic ring assay. Angiogenesis 4 (2001) 133-142
26. Villaschi S., and Nicosia R.F. Angiogenic role of endogenous basic fibroblast growth factor released by rat aorta after injury. Am. J. Pathol. 143 (1993) 181-190
27. Nicosia R.F., Nicosia S.V., and Smith M. Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. Am. J. Pathol. 145 (1994) 1023-1029
28. Masson Ve.V., Devy L., Grignet-Debrus C., Bernt S.B.K., Blacher S., Roland G., Chang Y., Fong T., Carmeliet P., Foidart J.M., and Noel A. Mouse aortic ring assay: a new approach of the molecular genetics of angiogenesis. Biol. Proced. Online 4 (2002) 24-31
29. Berger A.C., Wang X.Q., Zalatoris A., Cenna J., and Watson J.C. A murine model of ex vivo angiogenesis using aortic disks grown in fibrin clot. Microvasc. Res. 68 (2004) 179-187
30. Hosokawa H., Ninomiya H., Kitamura Y., Fujiwara K., and Masaki T. Vascular endothelial cells that express dystroglycan are involved in angiogenesis. J. Cell Sci. 115 (2002) 1487-1496
31. Hobson B., and Denekamp J. Endothelial proliferation in tumours and normal tissues: continuous labelling studies. Br. J. Cancer 49 (1984) 405-413
32. Kubota Y., Kleinman H.K., Martin G.R., and Lawley T.J. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J. Cell Biol. 107 (1988) 1589-1598
33. Shibuya M. Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. Cell Struct. Funct. 26 (2001) 25-35
34. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat. Med. 9 (2003) 669-676
35. Millauer B., Wizigmann-Voos S., Schnurch H., Martinez R., Moller N.P., Risau W., and Ullrich A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72 (1993) 835-846
36. Liotta L.A., and Kohn E.C. The microenvironment of the tumour-host interface. Nature 411 (2001) 375-379
37. Toker A., and Cantley L.C. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387 (1997) 673-676
38. Toker A., and Cantley L.C. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387 (1997) 673-676
39. Alessi D.R., James S.R., Downes C.P., Holmes A.B., Gaffney P.R.J., Reese C.B., and Cohen P. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B. Curr. Biol. 7 (1997) 261-269
40. Shiojima I., and Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ. Res. 90 (2002) 1243-1250
41. Cross M.J., and Claesson-Welsh L. FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol. Sci. 22 (2001) 201-207